International Journal of Cancer Management

Published by: Kowsar
Crossmark

Seroprevalence of Cytomegalovirus Antibodies and Primary Infection among Women and Infants in Iran: A Meta-Analysis

Fereshteh Farshidi 1 , Ghasem Abedi 2 , Mahmood Moosazadeh 3 , * and Mahdi Afshari 4
Authors Information
1 MSc, Health Sciences Research Center, Mazandaran University of Medical Sciences, Sari, Iran
2 Associate Professor, Department of Public Health, Health Sciences Research Center, Faculty of Health, Mazandaran University of Medical Sciences, Sari, Iran
3 Assistant Professor, Health Sciences Research Center, Mazandaran University of Medical Sciences, Sari, Iran
4 Department of Community Medicine, Zabol University of Medical Sciences, Zabol, Iran
Article information
  • Iranian Journal of Cancer Prevention: January 2017, 10 (1); e3704
  • Published Online: October 5, 2016
  • Article Type: Review Article
  • Received: July 28, 2015
  • Revised: September 24, 2016
  • Accepted: September 24, 2016
  • DOI: 10.17795/ijcp-3704

How to Cite: Farshidi F, Abedi G, Moosazadeh M, Afshari M. Seroprevalence of Cytomegalovirus Antibodies and Primary Infection among Women and Infants in Iran: A Meta-Analysis, Int J Cancer Manag. 2017 ; 10(1):e3704. doi: 10.17795/ijcp-3704.

Abstract
Copyright © 2016, Iranian Journal of Cancer Prevention. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Materials and Methods
3. Results
4. Discussion
Acknowledgements
Footnotes
References
  • 1. Sever JL. Pediatric cytomegalovirus infections. Clin Appl Immunol Rev. 2002; 3(1-2) : 47 -59 [DOI]
  • 2. Revello MG, Gerna G. Pathogenesis and prenatal diagnosis of human cytomegalovirus infection. J Clin Virol. 2004; 29(2) : 71 -83 [PubMed]
  • 3. Delfan-Beiranvand M, Pournia Y, Fazeli M, Tarvand AH, Hosseini J, Mirzaei M. Seroprevalence of cytomegalovirus infection in blood donors in Khorramabad. Iran J Virol. 2012; 6(1) : 1 -5
  • 4. Rajaii M, Nezami N, Pourhassan A, Naghili B, Fardiazar Z, Farzadi L. Serological elisa test (igm & igg) for prospective study of cytomegalovirus (cmv) infection in pregnant women. Iran J Publ Health. 2009; 38(3) : 109 -12
  • 5. Gaytant MA, Steegers EA, Semmekrot BA, Merkus HM, Galama JM. Congenital cytomegalovirus infection: review of the epidemiology and outcome. Obstet Gynecol Surv. 2002; 57(4) : 245 -56 [PubMed]
  • 6. Lazzarotto T, Ripalti A, Bergamini G, Battista MC, Spezzacatena P, Campanini F, et al. Development of a new cytomegalovirus (CMV) immunoglobulin M (IgM) immunoblot for detection of CMV-specific IgM. J Clin Microbiol. 1998; 36(11) : 3337 -41 [PubMed]
  • 7. Collinet P, Subtil D, Houfflin-Debarge V, Kacet N, Dewilde A, Puech F. Routine CMV screening during pregnancy. Eur J Obstet Gynecol Reprod Biol. 2004; 114(1) : 3 -11 [DOI][PubMed]
  • 8. Janan A, Honarmand H, Mozafari N, Asgharnia M, Janan A. Seroprevalence of cytomegalovirus in spontaneous abortion. IJOGI. 2014; 17(102) : 12 -9
  • 9. Munro SC, Hall B, Whybin LR, Leader L, Robertson P, Maine GT, et al. Diagnosis of and screening for cytomegalovirus infection in pregnant women. J Clin Microbiol. 2005; 43(9) : 4713 -8 [DOI][PubMed]
  • 10. Boppana SB, Pass RF, Britt WJ, Stagno S, Alford CA. Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality. Pediatr Infect Dis J. 1992; 11(2) : 93 -9 [PubMed]
  • 11. Arabzadeh SA, Mosavat SA, Eftekhari N. Seroepidemiology of human cytomegalovirus in pregnant women and their neonates in kerman city during 2005. J Kerman Univ Med Sci. 2007; 14(4) : 279 -88
  • 12. Mostafavi SN, Ataei B, Nokhodian Z, Yaran M, Babak A, Salehi A, et al. Seroprevalence of Cytomegalovirus infection and estimate of congenital Cytomegalovirus infection in Isfahan state, Iran: A population based study. Pakistan J Med Sci. 2013; 29(1)[DOI]
  • 13. Monavari SH, Keyvani H, Abedi Kiasari B, Mollaei H, Fazlalipour M, Salehi Vaziri M, et al. Detection of cytomegalovirus (CMV) antibodies or DNA sequences from ostensibly healthy Iranian mothers and their neonates. Inter J Med Med Sci. 2012; 4(8) : 155 -9
  • 14. Liesnard C, Donner C, Brancart F, Gosselin F, Delforge ML, Rodesch F. Prenatal diagnosis of congenital cytomegalovirus infection: prospective study of 237 pregnancies at risk. Obstet Gynecol. 2000; 95(6 Pt 1) : 881 -8 [PubMed]
  • 15. Ornoy A, Diav-Citrin O. Fetal effects of primary and secondary cytomegalovirus infection in pregnancy. Reprod Toxicol. 2006; 21(4) : 399 -409 [DOI][PubMed]
  • 16. Arabpour M, Kaviyanee K, Jankhah A, Yaghobi R. Human cytomegalovirus infection in women of childbearing age throughout Fars Province - Iran: a population-based cohort study. Malaysian J Microbiol. 2007; 3(2) : 23 -8
  • 17. Smithers-Sheedy H, Raynes-Greenow C, Badawi N, Khandaker G, Menzies R, Jones CA. Cytomegalovirus-related childhood mortality in Australia 1999-2011. J Paediatr Child Health. 2015; 51(9) : 901 -5 [DOI][PubMed]
  • 18. Moosazadeh M, Nekoei-Moghadam M, Emrani Z, Amiresmaili M. Prevalence of unwanted pregnancy in Iran: a systematic review and meta-analysis. Int J Health Plann Manage. 2014; 29(3) -90 [DOI][PubMed]
  • 19. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Prev Med. 2007; 45(4) : 247 -51 [DOI][PubMed]
  • 20. Erfanianahmadpoor M, Nasiri R, Vakili R, Hassannia T. Seroprevalence, transmission, and associated factors of specific antibodies against cytomegalovirus among pregnant women and their infants in a regional study. Saudi Med J. 2014; 35(4) : 360 -4 [PubMed]
  • 21. Janan A, Honarmand H, Amirmozafari N, Asgharnia M, Janan A. Study on Seroprevalence of Cytomegalovirus in Pregnant Women and the Association of Cytomegalovirus Seropositivity to Spontaneous Abortion. J Mazand Univ Med Sci. 2013; 23(105) : 36 -42
  • 22. Siadati A, Noorbakhsh S, Ghazi F, Rimaz SH, Monavari MR. Cytomegalovirus Infection In Primipiparous Pregnant Women And Their Neonates. Acta Medica Iran. 2002; 40(3) : 136 -9
  • 23. Bagheri L, Mokhtarian H, Sarshar N, Ghahramani M. Seroepidemiology of cytomegalovirus infection during pregnancy in Gonabad, east of Iran: a cross-sectional study. J Res Health Sci. 2012; 12(1) : 38 -44 [PubMed]
  • 24. Tabatabaee M, Tayyebi D. Seroepidemiologic study of human cytomegalovirus in pregnant women in Valiasr Hospital of Kazeroon, Fars, Iran. J Matern Fetal Neonatal Med. 2009; 22(6) : 517 -21 [DOI][PubMed]
  • 25. Falahi SH, Ravanshad M, Kenar koohi A, Karimi MA. SeroPrevalence of CMV in women's with spontaneous abortion in kowsar hospital, Ilam during 2007-2008. Modarres J Med Sci. 2010; 12(4) : 39 -43
  • 26. Zandieh T, Kavyani S, Rakhshan M. The evaluation of cytomegalovirus in infants following exchange transfusion in children medical hospital. SJIBTO. 2005; : 83 -9
  • 27. Golalipour MJ, Khodabakhshi B, Ghaemi E. The prevalance of TORCH antibodies among newborns with congenital malformations and their mothers in Gorgan, Iran. J Gorgan Univ Med Sci. 2008; 10(3) : 45 -50
  • 28. Mehrkhani F, Jam S, Sabzvari D, Fattahi F, Kourorian Z, SeyedAlinaghi S, et al. Cytomegalovirus co-infection in patients with human immunodeficiency virus in Iran. Acta Med Iran. 2011; 49(8) : 551 -5 [PubMed]
  • 29. Sharifi Mood B, Naeini R, Sanei Moghadam E. Investigation of the prevalence of CMV antibodies in healthy female donors in Zahedan 1996. Journal of Women, Obstetrics, and Infertility. 2001; 4(7-8) : 80 -2
  • 30. Spano LC, Gatti J, Nascimento JP, Leite JP. Prevalence of human cytomegalovirus infection in pregnant and non-pregnant women. J Infect. 2004; 48(3) : 213 -20 [DOI][PubMed]
  • 31. Gonzalez-Garcia CL, Reyes-Mendez MA, Ortega-Pierres LE, Rodriguez-Sanchez AP, Sandoval-Guido V, Sereno-Colo JA. [Seroprevalence and detection of primary infection by cytomegalovirus with IgG avidity test during the first quarter of pregnancy]. Salud Publica Mex. 2014; 56(6) : 619 -24 [PubMed]
  • 32. Maingi Z, Nyamache AK. Seroprevalence of Cytomegalo Virus (CMV) among pregnant women in Thika, Kenya. BMC Res Notes. 2014; 7 : 794 [DOI][PubMed]
  • 33. Kamel N, Metwally L, Gomaa N, Sayed Ahmed WA, Lotfi M, Younis S. Primary cytomegalovirus infection in pregnant Egyptian women confirmed by cytomegalovirus IgG avidity testing. Med Princ Pract. 2014; 23(1) : 29 -33 [DOI][PubMed]
  • 34. Seo S, Cho Y, Park J. Serologic screening of pregnant Korean women for primary human cytomegalovirus infection using IgG avidity test. Korean J Lab Med. 2009; 29(6) : 557 -62 [DOI][PubMed]
  • 35. Alvarado-Esquivel C, Hernandez-Tinoco J, Sanchez-Anguiano LF, Ramos-Nevarez A, Cerrillo-Soto SM, Estrada-Martinez S, et al. Seroepidemiology of cytomegalovirus infection in pregnant women in Durango City, Mexico. BMC Infect Dis. 2014; 14 : 484 [DOI][PubMed]
  • 36. Saraswathy TS, Az-Ulhusna A, Asshikin RN, Suriani S, Zainah S. Seroprevalence of cytomegalovirus infection in pregnant women and associated role in obstetric complications: a preliminary study. Southeast Asian J Trop Med Public Health. 2011; 42(2) : 320 -2 [PubMed]
  • 37. Xu GL. [A study on cytomegalovirus infection in 199 pregnant women and their infants]. Zhonghua Fu Chan Ke Za Zhi. 1989; 24(3) : 130 -2 [PubMed]
  • 38. Al-Awadhi R, Al-Harmi J, Alfadhli S. Prevalence of cytomegalovirus DNA in cord blood and voided urine obtained from pregnant women at the end of pregnancy. Med Princ Pract. 2013; 22(2) : 194 -9 [DOI][PubMed]
  • 39. Gandhoke I, Aggarwal R, Lal S, Khare S. Congenital CMV infection in symptomatic infants in Delhi and surrounding areas. Indian J Pediatr. 2006; 73(12) : 1095 -7 [PubMed]
  • 40. Abou-El-Yazed E, El-Hoseny IM, Kasim K, El-Sadek AA, Amar A. Prevalence of cytomegalovirus infection among patients undergoing hemodialysis. Egypt J Immunol. 2008; 15(2) : 33 -41 [PubMed]
  • 41. Fowotade A, Okonko IO, Agbede OO, Suleiman ST. High seropositivity of IgG and IgM antibodies against cytomegalovirus (CMV) among HIV-1 seropositive patients in Ilorin, Nigeria. Afr Health Sci. 2015; 15(1) : 1 -9 [DOI][PubMed]
  • 42. Ouedraogo AS, Yameogo JT, Poda GE, Kientega Y, Ouedraogo Traore R. [Prevalence of anti-CMV antibodies in blood donors in Ouagadougou (Burkina Faso)]. Med Sante Trop. 2012; 22(1) : 107 -9 [DOI][PubMed]
  • 43. Njeru DG, Mwanda WO, Kitonyi GW, Njagi EC. Prevalence of cytomegalovirus antibodies in blood donors at the National Blood Transfusion Centre, Nairobi. East Afr Med J. 2009; 86(12 Suppl) -61 [PubMed]
  • 44. Vochem M. [CMV infections of the neonate: prevalence, diagnosis, therapy]. Z Geburtshilfe Neonatol. 2003; 207(3) : 114 -8 [DOI][PubMed]
  • 45. Azam AZ, Vial Y, Fawer CL, Zufferey J, Hohlfeld P. Prenatal diagnosis of congenital cytomegalovirus infection. Obstet Gynecol. 2001; 97(3) : 443 -8 [PubMed]
  • 46. Seror J, Bordes P, Luton D. [Routine screening for CMV during pregnancy: practices assessment in Ile-de-France]. Gynecol Obstet Fertil. 2013; 41(10) : 578 -82 [DOI][PubMed]
  • 47. Johnson JM, Anderson BL. Cytomegalovirus: should we screen pregnant women for primary infection? Am J Perinatol. 2013; 30(2) : 121 -4 [DOI][PubMed]
  • 48. Bergallo M, Costa C, Tarallo S, Daniele R, Merlino C, Segoloni GP, et al. Development of a quantitative-competitive PCR for quantification of human cytomegalovirus load and comparison with antigenaemia, viraemia and pp67 RNA detection by nucleic acid sequence-based amplification. Panminerva Med. 2006; 48(2) : 119 -27 [PubMed]
  • 49. Delfan-Beiranvand M, Pournia Y, Fazeli M, Tarvand AH, Hosseini J, Mirzaei M. Seroprevalence of cytomegalovirus infection in blood donors in Khorramabad. Iranian J Virol. 2012; 6(1) : 1 -5
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments